Arcus Biosciences Inc. Revenue 2017–2025
Arcus Biosciences Inc. annual/quarterly revenue history and growth rate from 2017 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arcus Biosciences Inc. revenue for the quarter ending March 31, 2026 was 7.0 M, a 12.50% decrease year-over-year.
- Arcus Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 29.0 M, a 51.67% decrease year-over-year.
- Arcus Biosciences Inc. annual revenue for 2025 was 33.0 M, a 35.29% decrease from 2024.
- Arcus Biosciences Inc. annual revenue for 2024 was 51.0 M, a 37.84% increase from 2023.
- Arcus Biosciences Inc. annual revenue for 2023 was 37.0 M, a 2.63% decrease from 2022.
- Arcus Biosciences Inc. annual revenue for 2022 was 38.0 M.
Arcus Biosciences Inc. (RCUS) — Frequently Asked Questions
Arcus Biosciences Inc. (RCUS) is a publicly traded US company. It has a market capitalization of $2.38B. In fiscal 2025 it reported revenue of $33M and net income of -$353M. Explore RCUS's stock price, financial statements, earnings history, margins and key ratios below.
What is Arcus Biosciences Inc.'s market cap?
Arcus Biosciences Inc. (RCUS) has a market capitalization of $2.38B.
What is the RCUS stock price?
RCUS trades at $22.12 (-6.43% on the day).
How much revenue does Arcus Biosciences Inc. make?
Arcus Biosciences Inc. reported revenue of $33M in fiscal 2025.
Is RCUS profitable?
In fiscal 2025, Arcus Biosciences Inc. reported net income of -$353M.